Active

Guideline for the treatment of breakthrough and the prevention of refractory chemotherapy‐induced nausea and vomiting in children with cancer

Overview

Scope: Treatment of breakthrough chemotherapy induced nausea and vomiting (CINV) and the prevention of refractory CINV in children.

Guidance type: Clinical practice guideline

Methods: An international and multidisciplinary panel used the GRADE approach to develop recommendations based on the results of systematic reviews of the literature.

Discover

View our guidance library

Explore guidance for providing optimal supportive care to children receiving cancer treatments or undergoing bone marrow transplant.

Stay connected

Sign up to receive the iPOG Network quarterly newsletter!